Behavioral Benefits of COVID Lockdown for Heart Failure Patients: A New Therapeutic Intervention?
Publication
, Journal Article
O'Connor, C
Published in: JACC Heart Fail
February 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JACC Heart Fail
DOI
EISSN
2213-1787
Publication Date
February 2022
Volume
10
Issue
2
Start / End Page
142 / 143
Location
United States
Related Subject Headings
- SARS-CoV-2
- Humans
- Heart Failure
- Communicable Disease Control
- COVID-19
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
O’Connor, C. (2022). Behavioral Benefits of COVID Lockdown for Heart Failure Patients: A New Therapeutic Intervention? JACC Heart Fail, 10(2), 142–143. https://doi.org/10.1016/j.jchf.2021.12.001
O’Connor, Christopher. “Behavioral Benefits of COVID Lockdown for Heart Failure Patients: A New Therapeutic Intervention?” JACC Heart Fail 10, no. 2 (February 2022): 142–43. https://doi.org/10.1016/j.jchf.2021.12.001.
O’Connor C. Behavioral Benefits of COVID Lockdown for Heart Failure Patients: A New Therapeutic Intervention? JACC Heart Fail. 2022 Feb;10(2):142–3.
O’Connor, Christopher. “Behavioral Benefits of COVID Lockdown for Heart Failure Patients: A New Therapeutic Intervention?” JACC Heart Fail, vol. 10, no. 2, Feb. 2022, pp. 142–43. Pubmed, doi:10.1016/j.jchf.2021.12.001.
O’Connor C. Behavioral Benefits of COVID Lockdown for Heart Failure Patients: A New Therapeutic Intervention? JACC Heart Fail. 2022 Feb;10(2):142–143.
Published In
JACC Heart Fail
DOI
EISSN
2213-1787
Publication Date
February 2022
Volume
10
Issue
2
Start / End Page
142 / 143
Location
United States
Related Subject Headings
- SARS-CoV-2
- Humans
- Heart Failure
- Communicable Disease Control
- COVID-19
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology